Transcriptome signature for dampened Th2 dominance in acellular pertussis vaccine-induced CD4+ T cell responses through TLR4 ligation

Current acellular pertussis (aP) vaccines promote a T helper 2 (Th2)-dominated response, while Th1/Th17 cells are protective. As our previous study showed, after adding a non-toxic TLR4 ligand, LpxL1, to the aP vaccine in mice, the Bordetella pertussis-specific Th2 response is decreased and Th1/Th17 responses are increased as measured at the cytokine protein level. However, how this shift in Th response by LpxL1 addition is regulated at the gene expression level remains unclear. Transcriptomics analysis was performed on purified CD4+ T cells of control and vaccinated mice after in vitro restimulation with aP vaccine antigens. Multiple key factors in Th differentiation, including transcription factors, cytokines, and receptors, were identified within the differentially expressed genes. Upregulation of Th2- and downregulation of follicular helper T cell-associated genes were found in the CD4+ T cells of both aP- and aP+LpxL1-vaccinated mice. Genes exclusively upregulated in CD4+ T cells of aP+LpxL1-vaccinated mice included Th1 and Th17 signature cytokine genes Ifng and Il17a respectively. Overall, our study indicates that after addition of LpxL1 to the aP vaccine the Th2 component is not downregulated at the gene expression level. Rather an increase in expression of Th1- and Th17-associated genes caused the shift in Th subset outcome.

[1]  J. Kolls,et al.  Human TH17 cells express a functional IL-13 receptor and IL-13 attenuates IL-17A production. , 2011, The Journal of allergy and clinical immunology.

[2]  C. Locht,et al.  Cellular Immune Responses of Preterm Infants after Vaccination with Whole-Cell or Acellular Pertussis Vaccines , 2009, Clinical and Vaccine Immunology.

[3]  David J. Arenillas,et al.  oPOSSUM-3: Advanced Analysis of Regulatory Motif Over-Representation Across Genes or ChIP-Seq Datasets , 2012, G3: Genes | Genomes | Genetics.

[4]  Changhao Wu,et al.  Complement C3a binding to its receptor as a negative modulator of Th2 response in liver injury in trichloroethylene-sensitized mice. , 2014, Toxicology letters.

[5]  Terence P. Speed,et al.  A comparison of normalization methods for high density oligonucleotide array data based on variance and bias , 2003, Bioinform..

[6]  F. Hug,et al.  The complement receptor 3, CR3 (CD11b/CD18), on T lymphocytes: activation‐dependent up‐regulation and regulatory function , 2001, European journal of immunology.

[7]  Matias Ostrowski,et al.  Glucose Metabolism Regulates T Cell Activation, Differentiation, and Functions , 2014, Front. Immunol..

[8]  C. Locht,et al.  Modulation of the infant immune responses by the first pertussis vaccine administrations. , 2007, Vaccine.

[9]  C. Chen,et al.  Induced Expression of FcγRIIIa (CD16a) on CD4+ T Cells Triggers Generation of IFN-γhigh Subset* , 2015, The Journal of Biological Chemistry.

[10]  Chris T. A. Evelo,et al.  User-friendly solutions for microarray quality control and pre-processing on ArrayAnalysis.org , 2013, Nucleic Acids Res..

[11]  W. Wood,et al.  Krüppel‐like factor 4 (KLF4) directly regulates proliferation in thymocyte development and IL‐17 expression during Th17 differentiation , 2011, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[12]  David C. Gondek,et al.  Cutting Edge: Contact-Mediated Suppression by CD4+CD25+ Regulatory Cells Involves a Granzyme B-Dependent, Perforin-Independent Mechanism1 , 2005, The Journal of Immunology.

[13]  O. Götze,et al.  Activated Human T Lymphocytes Express a Functional C3a Receptor1 , 2000, The Journal of Immunology.

[14]  A. Beg,et al.  The Th17 immune response is controlled by a c-Rel-ROR{gamma}-ROR{gamma}T transcriptional axis , 2010 .

[15]  S. Abrignani,et al.  Role of microRNAs and long‐non‐coding RNAs in CD4+ T‐cell differentiation , 2013, Immunological reviews.

[16]  C. Dong,et al.  Toll-like receptor 4 signaling in T cells promotes autoimmune inflammation , 2012, Proceedings of the National Academy of Sciences.

[17]  R. Myers,et al.  Evolving gene/transcript definitions significantly alter the interpretation of GeneChip data , 2005, Nucleic acids research.

[18]  J. Seavitt,et al.  Aiolos promotes TH17 differentiation by directly silencing Il2 expression , 2012, Nature Immunology.

[19]  A. Beg,et al.  The Th17 immune response is controlled by the Rel–RORγ–RORγT transcriptional axis , 2011, The Journal of experimental medicine.

[20]  T. Merkel,et al.  Bordetella pertussis infection induces a mucosal IL-17 response and long-lived Th17 and Th1 immune memory cells in nonhuman primates , 2012, Mucosal Immunology.

[21]  Wei Liu,et al.  Bortezomib regulates the chemotactic characteristics of T cells through downregulation of CXCR3/CXCL9 expression and induction of apoptosis , 2012, International Journal of Hematology.

[22]  K. Hozumi,et al.  Notch controls the survival of memory CD4+ T cells by regulating glucose uptake , 2014, Nature Medicine.

[23]  Ming O. Li,et al.  Signaling through C5a receptor and C3a receptor diminishes function of murine natural regulatory T cells , 2013, The Journal of experimental medicine.

[24]  C. Drouet,et al.  Human complement C3 deficiency: Th1 induction requires T cell-derived complement C3a and CD46 activation. , 2014, Molecular immunology.

[25]  Colm E. Nestor,et al.  Profiling of human CD4+ T-cell subsets identifies the TH2-specific noncoding RNA GATA3-AS1. , 2013, The Journal of allergy and clinical immunology.

[26]  Mario Roederer,et al.  Single-cell technologies for monitoring immune systems , 2014, Nature Immunology.

[27]  H. Vié,et al.  Effector Memory αβ T Lymphocytes Can Express FcγRIIIa and Mediate Antibody-Dependent Cellular Cytotoxicity1 , 2008, The Journal of Immunology.

[28]  I. Gery,et al.  Suppressors of Cytokine Signaling Proteins Are Differentially Expressed in Th1 and Th2 Cells: Implications for Th Cell Lineage Commitment and Maintenance , 2002, The Journal of Immunology.

[29]  P. Conti,et al.  CD4+/CD25+ T cells suppress autologous CD4+/CD25- lymphocytes and secrete granzyme B during acute and chronic hepatitis C. , 2014, Pathogens and disease.

[30]  J. Pennings,et al.  Molecular Signatures of the Evolving Immune Response in Mice following a Bordetella pertussis Infection , 2014, PloS one.

[31]  M. Karin,et al.  The two NF-kappaB activation pathways and their role in innate and adaptive immunity. , 2004, Trends in immunology.

[32]  A. Morinobu,et al.  Podoplanin is an inflammatory protein upregulated in Th17 cells in SKG arthritic joints. , 2013, Molecular immunology.

[33]  E. Esplugues,et al.  Bcl6 expression specifies the T follicular helper cell program in vivo , 2012, The Journal of experimental medicine.

[34]  M. Klemsz,et al.  PU.1 expression delineates heterogeneity in primary Th2 cells. , 2005 .

[35]  A. Bar-Or,et al.  TLR2 Stimulation Drives Human Naive and Effector Regulatory T Cells into a Th17-Like Phenotype with Reduced Suppressive Function , 2011, The Journal of Immunology.

[36]  Andrew J. Black,et al.  Stochasticity in staged models of epidemics: quantifying the dynamics of whooping cough , 2010, Journal of The Royal Society Interface.

[37]  N. Miyasaka,et al.  SOCS-3 inhibits IL-12-induced STAT4 activation by binding through its SH2 domain to the STAT4 docking site in the IL-12 receptor beta2 subunit. , 2003, Biochemical and biophysical research communications.

[38]  K. Mills,et al.  Bordetella pertussis respiratory infection in children is associated with preferential activation of type 1 T helper cells. , 1997, The Journal of infectious diseases.

[39]  Anthony Bosco,et al.  A genomics-based approach to assessment of vaccine safety and immunogenicity in children. , 2012, Vaccine.

[40]  M. Karin,et al.  The two NF-κB activation pathways and their role in innate and adaptive immunity , 2004 .

[41]  Lisa M. Ebert,et al.  Flt3 ligand expands CD4+FoxP3+ regulatory T cells in human subjects , 2013, European journal of immunology.

[42]  J. Atkinson,et al.  T-cell regulation: with complements from innate immunity , 2007, Nature Reviews Immunology.

[43]  David H. Lee,et al.  T‐bet, a Th1 transcription factor regulates the expression of Tim‐3 , 2010, European journal of immunology.

[44]  K. Mills,et al.  Relative Contribution of Th1 and Th17 Cells in Adaptive Immunity to Bordetella pertussis: Towards the Rational Design of an Improved Acellular Pertussis Vaccine , 2013, PLoS pathogens.

[45]  J. Cherry The present and future control of pertussis. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[46]  F. Mooi,et al.  The Bordetella pertussis virulence factor P.69 pertactin retains its immunological properties after overproduction in Escherichia coli. , 2005, Protein expression and purification.

[47]  H. Vié,et al.  Effector memory alphabeta T lymphocytes can express FcgammaRIIIa and mediate antibody-dependent cellular cytotoxicity. , 2008, Journal of immunology.

[48]  H. Ochi,et al.  Lipid A directly inhibits IL‐4 production by murine Th2 cells but does not inhibit IFN‐γ production by Th1 cells , 1999, European journal of immunology.

[49]  Lai Wei,et al.  IL-21 Is Produced by Th17 Cells and Drives IL-17 Production in a STAT3-dependent Manner* , 2007, Journal of Biological Chemistry.

[50]  B. Zomer,et al.  Modification of Lipid A Biosynthesis inNeisseria meningitidis lpxL Mutants: Influence on Lipopolysaccharide Structure, Toxicity, and Adjuvant Activity , 2001, Infection and Immunity.

[51]  B. Faubert,et al.  Posttranscriptional Control of T Cell Effector Function by Aerobic Glycolysis , 2013, Cell.

[52]  Jinfang Zhu,et al.  Transcriptional regulatory networks for CD4 T cell differentiation. , 2014, Current topics in microbiology and immunology.

[53]  D. Jarrossay,et al.  Surface phenotype and antigenic specificity of human interleukin 17–producing T helper memory cells , 2007, Nature Immunology.

[54]  L. Hennighausen,et al.  Selective regulatory function of Socs3 in the formation of IL-17-secreting T cells. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[55]  K. Mills,et al.  A novel TLR2 agonist from Bordetella pertussis is a potent adjuvant that promotes protective immunity with an acellular pertussis vaccine , 2014, Mucosal Immunology.

[56]  C. Boog,et al.  Modulation of the CD4(+) T cell response after acellular pertussis vaccination in the presence of TLR4 ligation. , 2015, Vaccine.

[57]  S. Akira,et al.  Cutting Edge: TLR2 Directly Triggers Th1 Effector Functions1 , 2007, The Journal of Immunology.

[58]  Hiroshi I. Suzuki,et al.  miR-135b mediates NPM-ALK-driven oncogenicity and renders IL-17-producing immunophenotype to anaplastic large cell lymphoma. , 2011, Blood.

[59]  P. Zipfel,et al.  Synthesis of the CC-chemokines MIP-1alpha, MIP-1beta, and RANTES is associated with a type 1 immune response. , 1996, Journal of immunology.

[60]  Brad T. Sherman,et al.  Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources , 2008, Nature Protocols.

[61]  M. Huber,et al.  c‐Rel is crucial for the induction of Foxp3+ regulatory CD4+ T cells but not TH17 cells , 2010, European journal of immunology.

[62]  Jing Sun,et al.  Critical roles of c-Rel in autoimmune inflammation and helper T cell differentiation. , 2002, The Journal of clinical investigation.